Fig. 3: ASB16-AS1 inhibits xenograft tumor growth.

a SW-13 cells stably expressing ASB16-AS1 or control cells were injected into nude mice and xenograft tumors were dissected from nude mice 27 days after injection (n = 6 per group). b, c Enhanced ASB16-AS1 reduces the tumor weight and tumor volumes in xenograft tumors. SW-13 cells stably expressing ASB16-AS1 was injected into nude mice and tumor weight was measured 27 days post injection (b) and tumor volumes was measured 7 days after injection (c). *P < 0.05 versus control. d Histopathology of xenograft tumors derived from SW-13 cells stably expressing ASB16-AS1. Xenograft tumors derived from SW-13 cells were sectioned and stained by HE staining and immunohistochemical staining using Ki-67 staining. Scale bar equals 100 μm.